THE 2006 LIVING LEGEND INDUCTEES
Brief summaries of each of the 2006 "Living Legend" inductees are provided below in alphabetical order:
Dr. Donald Beanlands
Dr. Beanlands (Fig. 2) Known internationally for his teaching, Dr. Beanlands has led national and international training programs and has received many awards for them, including, on two occasions, the Excellence in Clinical Teaching Award for postgraduate training at the Faculty of Medicine. Dr. Beanlands is recognized as one of Canada's top specialists in Cardiology and has been an investigator in more than 50 research studies, publishing more than 100 articles. He has chaired numerous committees at both the University of Ottawa and the Heart Institute. He served as Chairman of Cardiology for the Ontario Medical Association, and as the Governor for Ontario for both the American College of Cardiology and the American Heart Association. He has been an Internal and External Reviewer for both the Heart and Stroke Foundation of Ontario and Canada, the American College of Cardiology, the Medical Research Council of Canada, and the American Heart Association. He has been active in the development of national guidelines for clinical practice and was a member of the Cardiac Care Network of Ontario from 1990 to 1997. In 1997, he was appointed to the Ottawa-Carleton District Health Council, now known as the Champlain District Health Council. Dr. Beanlands' research interest focused on methods of treatment of non-reperfusable intractable angina.
Dr. Denton Cooley
Dr. Cooley (Fig. 3) , a son of a Houston dentist, was born in 1920. He In 1981 Dr. de Bold discovered, isolated and sequenced the cardiac polypeptide hormone named Atrial Natriuretic Factor (ANF), thus establishing that the heart has an endocrine function. His work on ANF has been recognized through numerous distinctions and awards. He has also received numerous distinctions in his native country of Argentina. The multiple properties of ANF have provided many new avenues of research in cardiovascular physiology as well as in very important clinical entities such as hypertension and heart failure. More than 15,000 scientific papers published to date attest to the importance of the ANF discovery. Dr. de Bold has placed ANF within integrative physiology with several important contributions in prestigious journals. The discovery of ANF has made Dr. de Bold one of the most cited Canadian scientists. He has given more than 150 invited lectures worldwide on his field of interest. His work on ANF was declared the first of the top ten research accomplishments funded by the Ontario Heart and Stroke Foundation in the past 50 years.
Dr. O. Howard Frazier
Dr. Frazier (Fig. 5) is Chief of Cardiopulmonary Transplantation at the Texas Heart Institute, co-director of During his more than 20 years as director of cardiopulmonary transplantation, Dr. Frazier has guided the service into one of the top transplantation programs in the world. He has performed 1,000 heart transplants and implanted more than 661 left ventricular assist devices, more than any other surgeon in the world. He serves on the editorial boards of several distinguished medical journals, including Circulation, the premier journal of the American Heart Association. He has authored or coauthored more than 1,000 scientific publications, presented over 700 lectures around the world, and written or edited numerous books in the field of cardiovascular medicine. He is a former chairman of the Federal Affairs Committee for the American Society for Artificial Internal Organs and has served on other prominent committees, including the Education Committee of the American Society of Transplant Surgeons and the Advisory Board of the National Heart, Lung, and Blood Institute. In 2001, he was elected president of the American Society for Artificial Internal Organs.
Dr. Valentin Fuster
Dr. Fuster (Fig. 6 Katz's career is marked with "firsts" that include outstanding contributions in neurosurgery with Dr. Wilder Penfield and Les. A. Geddes: thyroid diagnosis and treatment using radioactive iodine; open heart bypass surgery with Dr. Edouard Gagnon and Dr. Arthur Vineberg; cardiac catheterization with Dr. Osman Gialloreto; whole-body by-pass perfusion during more than 1500 heart operations; vestibular disease; fetal cardiotachometry; arteriography and lymphoangiography; preparation and management of human arterial grafts; modernization and instrumentation of major hospitals; world standards for medical devices; legislative and regulatory control of medical devices; widespread publication of device-related hazards, accidents, and problems, particularly accidental misconnections; and discovery of the backflow and infection hazards from non-sterile evacuated blood collection tubes. Leon Katz is the author of many publications in international medical journals, and Member Emeritus of the Canadian Medical and Biological Engineering Society.
Dr. Terry Kavanagh
Dr. Kavanagh (Fig. 8 ) has achieved an international reputation as a pioneer, clinician, researcher, teacher, and advocate in cardiac rehabilitation, a field that has been largely structured as we know it today by his contributions. In 1968, as Medical Director of the Toronto Rehabilitation Centre, he introduced the cardiac rehabilitation program, which eventually became the largest in North America, and out of which came the first post-myocardial infarction patients to enter and complete the Boston Marathon. His contributions to the awareness of exercise as a protective and preventive measure for coronary heart disease are numerous, with more than 100 scientific publications as well as four editions of his bestselling book to help the lay reader attain heart health.
He 
Dr. Donald Olsen
During 50 years of very hard work in medical research closely related to veterinary medicine, Dr. Olsen (Fig. 9 ) has implanted total artificial hearts (TAHs) with cardiopulmonary bypass in thousands of calves and sheep, ventricular assist pumps (VADs) in many animals, including pigs, and has even recently done experimental cardiac surgery on alligators. He has about 300 peerreviewed publications, 10 chapters in books, and numerous national and international awards.
The 
Mr. Manny Villafaña
A leader in the cardiovascular industry, Manny Villafaña (Fig. 10) has founded or co-founded companies that are behind some of the most well-known heart valves today. 
Dr. James T. Willerson
Dr. Willerson (Fig. 11) His current research interests include the use of stem cells to improve severely damaged heart tissue. Dr. Willerson and his colleagues at the Texas Heart Institute now lead one of the first FDA-approved clinical trials to treat patients with end-stage heart disease using their own bone marrow-derived stem cells.
Dr. Earl Wynands
Dr Earl Wynands (Fig. 12 ) graduated from McGill University in 1954, where he obtained his specialist His major work has been concentrated on normal and malignant blood formation. With his colleague Dr. Till, he devised the first functional assay (the spleen colony assay) for primitive blood cell precursors (pluripotent stem cells or CFU-S). The discovery of the spleen colony assay for stem cells and its exploitation were major stimuli for the development of the field of experimental hematology. Since 1970, he has concentrated on the malignant cells characteristic of acute leukemia in man.
He has been an invited symposium or seminar speaker in many countries in North America, Europe, the Middle East and Asia, and in collaboration with his colleagues and students has reported his findings in 
SURPRISE AWARDS
Following the "Living Legends" ceremony, three surprise awards were also announced. In the first The 2 nd surprise award was presented to Dr. Wilbert J. Keon (Fig. 14) , in recognition of his contributions to humanity. This award was presented on the occasion of the 30 th Anniversary of his founding of the World Congress Host Organization, the University of Ottawa Heart Institute. Dr. Keon had previously been awarded the "Living Legends" award in 2001. The final surprise award was to Mrs. Ann Keon (Fig. 15 ) in recognition of her contributions to humanity related to her vital and under-recognized role in the development of the University of Ottawa Heart Institute into a world class healthcare and research institution.
CONCLUSIONS
The opportunity to participate in a gathering of such prestigious scientists is truly an inspiring experience. Through their work, this group of "Living Legends" has essentially shaped the future of healthcare. While each of these individuals has certainly displayed a common thirst for knowledge and a relentless drive, they have also undoubtedly endured major personal sacrifice to advance the science and art of medicine. These are not just great scientists, they are also true humanitarians. It was, therefore, my great honor to organize this event, one that will undoubtedly provide me with a constant source of motivation into the future. Since these awards have now become a permanent event to celebrate and pay homage to great achievement and even greater individuals in our field, I also look forward to the next series of "Living Legends".
